KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Total Liabilities (2016 - 2026)

CareDx's Total Liabilities history spans 14 years, with the latest figure at $97.5 million for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 11.57% to $97.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $97.5 million, a 11.57% decrease, with the full-year FY2025 number at $110.1 million, down 2.21% from a year prior.
  • Total Liabilities hit $97.5 million in Q1 2026 for CareDx, down from $110.1 million in the prior quarter.
  • Over the last five years, Total Liabilities for CDNA hit a ceiling of $205.5 million in Q4 2023 and a floor of $89.2 million in Q1 2022.
  • Historically, Total Liabilities has averaged $129.9 million across 5 years, with a median of $110.3 million in 2025.
  • The widest YoY moves for Total Liabilities: up 90.33% in 2024, down 45.2% in 2024.
  • Tracing CDNA's Total Liabilities over 5 years: stood at $112.1 million in 2022, then surged by 83.35% to $205.5 million in 2023, then tumbled by 45.2% to $112.6 million in 2024, then decreased by 2.21% to $110.1 million in 2025, then fell by 11.44% to $97.5 million in 2026.
  • Business Quant data shows Total Liabilities for CDNA at $97.5 million in Q1 2026, $110.1 million in Q4 2025, and $121.2 million in Q3 2025.